◆ 会议时间：2023年6月28日至7月1日
◆ 会议地点：西班牙 巴塞罗那（Barcelona, Spain）

◆ 会议简介：

2023年第25届ESMO世界胃道肠肿瘤大会(ESMO World GI 2023)将于2023年6月28日至7月1日在西班牙巴塞罗那举行，会议由欧洲肿瘤内科学会（ESMO）主办。ESMO世界消化道肿瘤大会是该领域首屈一指的全球性会议，会议内容包括影响胃肠道各组成部分的恶性肿瘤以及与胃肠癌患者护理相关的各个方面，包括筛查、诊断以及常见和罕见肿瘤的最新管理方案。大会将汇集来自世界各地的胃肠病学、肿瘤学、病理学和肝病学领域的一流专家、临床医生和外科医生以及临床研究人员，以分享治疗胃肠道癌症的开拓性研究、方法和最佳实践。2019年会议（WCGI2019）有来自全球 120多个国家和地区的3500余名专业人士与会。

欧洲肿瘤内科学会（ESMO）成立于1975年，是全球领先的肿瘤内科学专业组织。ESMO是肿瘤学教育和信息的参考学会，现在全球160多个国家和地区拥有超过25,000余名会员；ESMO致力于通过宣促进多学科的癌症护理，支持肿瘤学家的专业发展以及在全球倡导可持续的癌症护理，尽而为癌症患者提供最佳的护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

2023 ESMO World Congress on Gastrointestinal Cancer
Date: 28 June - 1 July 2023
Venue: CCIB - Centre de Convencions Internacional de Barcelona, Barcelona, Spain

The ESMO World Congress on Gastrointestinal Cancer represents the year’s premier gathering of international oncology professionals who are dedicated to improving the lives of patients impacted by diseases of the GI tract. The Congress is the leading global platform for discussing the latest emerging data and new research in this rapidly advancing scientific field.

摘要征文投稿：

Important Abstract Dates 

Submit your abstracts here: https://owpm1.com/abstracts/WGI/

Abstract Submission Guidelines
Participants interested in presenting data should submit abstracts online by 13MARCH 2023. Abstracts are subject to acceptance by the Scientific Committee. Once accepted, abstracts will be published in a supplement of Annals of Oncology and scheduled for oral or poster presentation. Acceptance notifications and guidelines for podium and poster presentations will be sent on 7 APRIL 2023. Authors of accepted abstracts who have not registered will have until 21 APRIL 2023 to do so at the early registration rate. 

Abstracts will be accepted in the following categories, and the author should indicate it as either BASIC or CLINICAL by choosing the appropriate category in the online submission system:

• Colon Cancer
• Esophageal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer
• Rectal Cancer
• Biliary Tract Cancer
• Neuroendocrine Tumors
• Others (including GIST and Anal Cancer)

Subcategories include:

• Biomarkers and Translational Research
• Early and Locally Advanced Disease
• Imaging
• Metastatic Disease
• Pathology
• Preclinical
• Radiotherapy
• Screening/Prevention/Epidemiology
• Surgery
• Others

Trials in Progress Abstract Submissions
The 25th World Congress on Gastrointestinal Cancer is accepting Trials in Progress abstract submissions in all phases of clinical research (phase I to phase III). All abstracts submitted as Trials in Progress are ongoing trials that have not reached any protocol-specific endpoint for analysis and will only require the completion of two sections: Background and Trial Design. It is a requirement that recruitment must have already begun or have been completed by the abstract submission deadline.

Abstract Guidelines

• Follow the online instructions
• Abstracts must be written in English
• All abstracts are considered for Oral Presentation. If not accepted for Oral, then ALL submissions will be considered for Poster Presentation
• The submitted work must not, nor will not have been:
  • published in any journal, or on any website before 28 June 2023, or
  • presented at any national or international scientific conference prior to 28 June 2023
  • Encore abstracts will be allowed if they contain new data. During the submission process you will be asked if the abstract has been presented before, when you say yes you will be prompted to submit the original abstract as a reference.
• Abstract body must have a 500-word count limit
• Use a concise title. Title should be in sentence case (eg: Using food science to enhance STEM education)
• List affiliations of author(s) as briefly as possible, with city, province/state and country
• Maximum number of authors: 22
• Use standard and well-accepted abbreviations
• Abstract content should be single-spaced and typed in lower case
• Abstracts shall be of original research and contain a concise statement of study aim
• Submit four (4) parts of your abstract: Background, Method, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable.
• Abstract submissions can only be completed and finalized once all authors have submitted their disclosures.  There is an ‘email author’ function to allow for submitters to send reminders to their co-authors to submit disclosures. The disclosure deadline will be the same as the submission deadline. NO exceptions will be made to this policy. 

Developing Nations Travel Awards
A limited number (5) of travel awards are available for investigators from developing nations. Awards are available to investigators from the countries indicated in the 2023 World Bank List of Economies as Lower-Middle Income Economies. The complete list can be found at http://www.worldbank.org

These awards will consist of Congress registration and a grant in the amount of €1500 to cover airfare and hotel, given to the recipient at the Congress. Airfare can be purchased by HMP Global and deducted from this amount, if needed. If you have questions about this information, please contact HMP Global.

Developing Nations Travel Award recipients from past congresses will not be eligible for this award.

How to Apply for Developing Nations Travel Awards:

• The candidate must submit an abstract to The 25th World Congress on Gastrointestinal Cancer in the usual manner, indicating that the abstract is to be considered for the Developing Nations Award
• The candidate must be the first author of the submitted abstract
• The work must not have been presented or published before the date of The 25th World Congress on Gastrointestinal Cancer
• Abstracts must be submitted on schedule
• Candidates should submit:
  • A Curriculum Vitae
  • A 1-3 page description of their interests and current research in gastrointestinal cancer signed and approved by their department chair

The Scientific Committee will select the award winners based on the scientific content of the abstract. Winners will be notified in April 2023.

Young Investigator Awards
A limited number (3) of Young Investigator Best Abstract Awards are available, upon application, to first author (= presenter) to candidates under the age of 35 who submit abstracts considered deserving of recognition.

These awards will consist of Congress registration and a grant in the amount of €1000, given to the recipient at the Congress. Airfare and hotel can be arranged by HMP Global for the Grant Recipient. The total amount of the airfare and hotel will be deducted from the grant amount awarded onsite. If you have questions about this information, please contact HMP Global.

Young Investigator Award recipients from past congresses will not be eligible for this award.

How do I apply for a young investigator award?

• The candidate must submit an abstract to The 25th World Congress on Gastrointestinal Cancer in the usual manner, indicating that the abstract is to be considered for the Young Investigator Award during submission.
• To be considered for the Young Investigator Award, candidates will be required to submit a brief summary (cannot exceed 500 words) of the findings of the abstract and their relevance to the topics presented at the Congress.
• The age if the candidate should be less than 35 years of age by the submission deadline (Age will be verified).
• The candidate must be the first and presenting author of the submitted abstract.
• The work must not have been presented or published before the date of The 25th World Congress on Gastrointestinal Cancer.

The Scientific Committee will select the award winners based on the scientific content of the abstract. Winners will be notified in April 2023.

Late-Breaking Abstract Submissions
The Congress late-breaking policy allows the submission of late-breaking abstracts defined as “high quality, new research findings from randomized phase II or phase III trials with implications for clinical practice or understanding of disease processes.”

An abstract template should be submitted by the regular abstract deadline (13 MARCH, 2023). The template should include: title, author list, and a description of the study. A final abstract version must be submitted by 15 JUNE, 2023 and will be published in a supplement of the Annals of Oncology. Abstract titles will be published on the meeting website ahead of the Congress. Please do not include any information you would like to remain embargoed in the title of your abstract.

Changes to Abstracts
You may change your abstract even after finalizing up until the submission deadline of 13 MARCH 2023, 17:00 CET. Once the submission site has closed, changes to abstracts will not be accepted.  

Abstract Withdrawal
Deadline for withdrawing abstracts is 17 APRIL 2023. The Congress will not make any exceptions to this rule. 

注册费：

◆ 参会对象：
肿瘤科医生，放射科医生，病理学家，消化科医生，外科医生，肝病学家，医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。